5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation.

Cho YH, Ro EJ, Yoon JS, Mizutani T, Kang DW, Park JC, Il Kim T, Clevers H, Choi KY. · 2020

Read 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation. by Cho YH, Ro EJ, Yoon JS, Mizutani T, Kang DW, Park JC, Il Kim T, Clevers H, Choi KY. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7578039.txt.

Description

Cho and co-authors show that 5-FU can promote stemness in colorectal cancer through p53. The drug 5-FU is first-line care for this cancer. Tumors often shrink at first, then return after treatment.

The team found p53 raises WNT3 gene activity. That switch turns on the WNT and beta-catenin pathway. Models included mice, patient tumor organoids and patient cells. Through this route, 5-FU enriched cancer stem cells. Those cells in leftover tumors drive recurrence. A WNT inhibitor paired with 5-FU suppressed stem cells. The pairing also cut tumor regrowth after treatment stopped. The findings suggest a new combination plan for colorectal cancer care.

Catalog record

CREATORCho YH, Ro EJ, Yoon JS, Mizutani T, Kang DW, Park JC, Il Kim T, Clevers H, Choi KY.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7578039

Browse the full library · About the Tower of Babel